Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China

BACKGROUND: Lamivudine (LMV), as the preferred oral drug for use in treatment of HBV, always results in development of resistance mutations after long-term treatment. In this study we investigated chronic hepatitis B (CHB) patients in southern China to determine whether different HBV genotypes affec...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Si-Yue, Qin, Li, Zhang, Lei, Song, Xing-Bo, Zhou, Yi, Zhou, Juan, Lu, Xiao-Jun, Cao, Ju, Wang, Lan-Lan, Wang, Jun, Ying, Bin-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2011
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539467/
https://www.ncbi.nlm.nih.gov/pubmed/21959623
http://dx.doi.org/10.12659/MSM.881965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539467/
https://www.ncbi.nlm.nih.gov/pubmed/21959623
http://dx.doi.org/10.12659/MSM.881965

Ejemplares similares